Growth Metrics

Bruker (BRKR) Liabilities and Shareholders Equity (2016 - 2026)

Bruker filings provide 16 years of Liabilities and Shareholders Equity readings, the most recent being $6.2 billion for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 7.49% to $6.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $24.9 billion, a 11.74% increase, with the full-year FY2025 number at $6.2 billion, up 7.49% from a year prior.
  • Liabilities and Shareholders Equity hit $6.2 billion in Q4 2025 for Bruker, down from $6.4 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $6.4 billion in Q3 2025 to a low of $3.0 billion in Q1 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $3.8 billion (2023), compared with a mean of $4.5 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: dropped 1.05% in 2022 and later skyrocketed 60.04% in 2024.
  • Bruker's Liabilities and Shareholders Equity stood at $3.6 billion in 2021, then dropped by 1.05% to $3.6 billion in 2022, then increased by 17.67% to $4.2 billion in 2023, then skyrocketed by 36.63% to $5.8 billion in 2024, then grew by 7.49% to $6.2 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $6.2 billion (Q4 2025), $6.4 billion (Q3 2025), and $6.3 billion (Q2 2025) per Business Quant data.